Search results
Results from the WOW.Com Content Network
Vanish is the global stain-remover market leader in the fabric-treatment category, which is sold in more than 60 countries across the globe. Vanish started as a stain-removing laundry product launched around 1983 by a small Scottish company called Projectina Co Ltd, established by Robert G. Macfarlane in Skelmorlie, Scotland. [ 3 ]
Both local and systemic side effects can result from topical corticosteroid use, especially in prolonged treatment. [39] Local side effects can occur regularly from prolonged use, [45] which include skin atrophy (thinning), stretch marks, infections, lighter skin color, and sudden decrease in efficacy of the drug. [39] [45]
Cetylpyridinium chloride is known to cause tooth staining in approximately 3 percent of users. [14] The Crest brand has noted that this staining is actually an indication that the product is working as intended, as the stains are a result of bacteria dying on the teeth. [15]
Pimecrolimus is an ascomycin macrolactam derivative. It has been shown in vitro that pimecrolimus binds to FKBP1A and also inhibits calcineurin. [citation needed] Thus pimecrolimus inhibits T-cell activation by inhibiting the synthesis and release of cytokines from T-cells.
Common side effects include headache, sore throat, eye discomfort, or changes in perception of taste. [3] [2] More significant side effects may include sleepiness. [2] It is unclear if use during pregnancy or breastfeeding is safe. [4] It is an antihistamine and mast cell stabilizer. [5] [2] Olopatadine was patented in 1986 and came into ...
It has estrogenic effects in bone and antiestrogenic effects in the breasts and uterus. [6] Raloxifene was approved for medical use in the United States in 1997. [6] It is available as a generic medication. [6] [8] In 2020, it was the 292nd most commonly prescribed medication in the United States, with more than 1 million prescriptions. [9] [10]
The most commonly reported adverse effects for IV formulations of acetylcysteine are rash, urticaria, and itchiness. [23] Adverse effects for inhalational formulations of acetylcysteine include nausea, vomiting, stomatitis, fever, rhinorrhea, drowsiness, clamminess, chest tightness, and bronchoconstriction. Although infrequent, bronchospasm has ...
Vaniqa is a cream, which is white to off-white in colour. It is supplied in tubes of 30 g and 60 g in Europe. [28] Vaniqa contains 15% w/w eflornithine hydrochloride monohydrate, corresponding to 11.5% w/w anhydrous eflornithine (EU), respectively 13.9% w/w anhydrous eflornithine hydrochloride (U.S.), in a cream for topical administration.